Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 28:7:185.
doi: 10.3389/fphar.2016.00185. eCollection 2016.

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading

Affiliations
Review

Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug Loading

Felicity Y Han et al. Front Pharmacol. .

Abstract

Poly(lactic-co-glycolic acid) (PLGA) is the most widely used biomaterial for microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens. PLGA has excellent biodegradability and biocompatibility and is generally recognized as safe by international regulatory agencies including the United States Food and Drug Administration and the European Medicines Agency. The physicochemical properties of PLGA may be varied systematically by changing the ratio of lactic acid to glycolic acid. This in turn alters the release rate of microencapsulated therapeutic molecules from PLGA microparticle formulations. The obstacles hindering more widespread use of PLGA for producing sustained-release formulations for clinical use include low drug loading, particularly of hydrophilic small molecules, high initial burst release and/or poor formulation stability. In this review, we address strategies aimed at overcoming these challenges. These include use of low-temperature double-emulsion methods to increase drug-loading by producing PLGA particles with a small volume for the inner water phase and a suitable pH of the external phase. Newer strategies for producing PLGA particles with high drug loading and the desired sustained-release profiles include fabrication of multi-layered microparticles, nanoparticles-in-microparticles, use of hydrogel templates, as well as coaxial electrospray, microfluidics, and supercritical carbon dioxide methods. Another recent strategy with promise for producing particles with well-controlled and reproducible sustained-release profiles involves complexation of PLGA with additives such as polyethylene glycol, poly(ortho esters), chitosan, alginate, caffeic acid, hyaluronic acid, and silicon dioxide.

Keywords: PLGA microparticles; biodegradation mechanisms; drug delivery system; hydrogel template; hydrophilic molecule; microfluidics; supercritical carbon dioxide; tuneable release.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abulateefeh S. R., Alkilany A. M. (2015). Synthesis and characterization of PLGA shell microcapsules containing aqueous cores prepared by internal phase separation. AAPS PharmSciTech. 16. [Epub ahead of print]. 10.1208/s12249-015-0413-y - DOI - PubMed
    1. Acharya G., Shin C. S., Mcdermott M., Mishra H., Park H., Kwon I. C., et al. . (2010a). The hydrogel template method for fabrication of homogeneous nano/microparticles. J. Control Release 141, 314–319. 10.1016/j.jconrel.2009.09.032 - DOI - PubMed
    1. Acharya G., Shin C. S., Vedantham K., Mcdermott M., Rish T., Hansen K., et al. . (2010b). A study of drug release from homogeneous PLGA microstructures. J. Control Release 146, 201–206. 10.1016/j.jconrel.2010.03.024 - DOI - PubMed
    1. Anderson J. M., Shive M. S. (1997). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28, 5–24. - PubMed
    1. Anderson J. M., Shive M. S. (2012). Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 64, 72–82. 10.1016/S0169-409X(97)00048-3 - DOI - PubMed